Skip to content

Ayurvedic clinical trial on high cholesterol

An open clinical trial to evaluate the efficacy of Vatsakadi Vati in management of hyperlipidemia - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059428
Enrollment
50
Registered
2023-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Vd Vaishali Shamrao Meshram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient irrespective of age, sex, religion etc.of Hyperlipidemia. 2.Patients with high blood lipid profile.Lipid profile showing any one or more of the following criteria was considered diagnostic of hyperlipidemia. 3.Patients with controlled Type 2 diabetes mellitus and hypertensive patients with blood pressure within the normal limits. 4.Obese Hyperlipidemic and Non-Obese hyperlipidemic Patients (BMI-18.50 to 40.00 kg/m2 as per New Updated WHO classification of BMI of 2004). 5.Patient having Serum Total Cholesterol Level >200mg/dl. 6.Patient having Serum LDL Cholesterol Level >130mg/dl 7.Patient having serum VLDL Cholesterol Level >40mg/dl. 8.Patient having Serum HDL Cholesterol Level 9.Patient having Serum Triglyceride Level >150mg/dl.

Exclusion criteria

Exclusion criteria: 1.Patients having a history of untreated thyroid disorder. 2.Pregnant women & lactating mother. 3.Chronic illness and infection like TB, CA and HIV infection. 4.Patient is suffering with psychological disorders like anxiety, depression. 5.Patient with Respiratory Diseases Complications, Coronary Heart Disease, Hepatic or Renal Disease etc. 6.Drug induced Hyperlipidemia.

Design outcomes

Primary

MeasureTime frame
1.Study to determine the effectiveness of Vatsakadi Vati in the dose of 500mg twice a day to maintain normal lipid profile level. Timepoint: 30th day,60th day

Secondary

MeasureTime frame
1.To study in detail about Medovriddhi according to Ayurvedic classics. 2.To study in detail about Hyperlipidemia according to modern medicine. Timepoint: 30th day, 60th day

Countries

India

Contacts

Public ContactVd Vaishali Shamrao Meshram

R.A.Podar Medical College, Worli, Mumbai-18

geeta.parulkar@gmail.com8652694332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026